-
1
-
-
0036233003
-
Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome
-
Kim Y-K, Pai H, Lee H-J, Park S-E, Choi E-H, Kim J, Kim J-H, Kim E-C (2002) Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 46:1481-1491
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 1481-1491
-
-
Kim, Y.-K.1
Pai, H.2
Lee, H.-J.3
Park, S.-E.4
Choi, E.-H.5
Kim, J.6
Kim, J.-H.7
Kim, E.-C.8
-
4
-
-
0027496629
-
Extended-spectrum β-lactamases in Escherichia coli and Klebsiella spp. in European septicemia isolates
-
Pornull KJ, Goransson E, Rytting AS, Dornbusch K (1993) Extended-spectrum β-lactamases in Escherichia coli and Klebsiella spp. in European septicemia isolates. J Antimicrob Chemother 32:559-570
-
(1993)
J Antimicrob Chemother
, vol.32
, pp. 559-570
-
-
Pornull, K.J.1
Goransson, E.2
Rytting, A.S.3
Dornbusch, K.4
-
5
-
-
0032701986
-
Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: Clinical features and identification of differential plasmids carrying both SHV-5 and TEM-1 genes
-
Siu LK, Lu PL, Hsueh PR, Lin FM, Chang SC, Luh KT, Ho M, Lee CY (1999) Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of differential plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol 37:4020-4027
-
(1999)
J Clin Microbiol
, vol.37
, pp. 4020-4027
-
-
Siu, L.K.1
Lu, P.L.2
Hsueh, P.R.3
Lin, F.M.4
Chang, S.C.5
Luh, K.T.6
Ho, M.7
Lee, C.Y.8
-
6
-
-
0035003640
-
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory
-
Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL (2001) Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39:2206-2212
-
(2001)
J Clin Microbiol
, vol.39
, pp. 2206-2212
-
-
Paterson, D.L.1
Ko, W.C.2
Von Gottberg, A.3
Casellas, J.M.4
Mulazimoglu, L.5
Klugman, K.P.6
Bonomo, R.A.7
Rice, L.B.8
McCormack, J.G.9
Yu, V.L.10
-
7
-
-
0032801296
-
Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with the Surveillance Network database-USA
-
Sahm DF, Marsilio MK, Piazza G (1999) Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with The Surveillance Network database-USA. Clin Infect Dis 29:259-263
-
(1999)
Clin Infect Dis
, vol.29
, pp. 259-263
-
-
Sahm, D.F.1
Marsilio, M.K.2
Piazza, G.3
-
9
-
-
3142564331
-
-
Société Française de Microbiologie
-
Garret G, Cavallo JD, Chardon H, Chidiac C, Choutet P, Courvalin P, Dabernat H, Drugeon H, Dubreuil L, Goldstein F, Jarlier V, Leclercq R, Nicolas-Chanoine MH, Philippen A, Quentin-Noury C, Rouveix B, Sirot J, Soussy CJ: Comité de L' Antibiogramme De La Societé Française de Microbiologie Communiqué 2000-2001 (2001) Société Française de Microbiologie. http://www.sftn.asso.fr/
-
(2001)
-
-
Garret, G.1
Cavallo, J.D.2
Chardon, H.3
Chidiac, C.4
Choutet, P.5
Courvalin, P.6
Dabernat, H.7
Drugeon, H.8
Dubreuil, L.9
Goldstein, F.10
Jarlier, V.11
Leclercq, R.12
Nicolas-Chanoine, M.H.13
Philippen, A.14
Quentin-Noury, C.15
Rouveix, B.16
Sirot, J.17
Soussy, C.J.18
-
11
-
-
0033963019
-
Screening and confirmatory testing for extended-spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates
-
Hadziyannis E, Tuohy M, Thomas L, Procop GW, Washington JA, Hall GS (2000) Screening and confirmatory testing for extended-spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates. Diagn Microbiol Infect Dis 36:113-117
-
(2000)
Diagn Microbiol Infect Dis
, vol.36
, pp. 113-117
-
-
Hadziyannis, E.1
Tuohy, M.2
Thomas, L.3
Procop, G.W.4
Washington, J.A.5
Hall, G.S.6
-
12
-
-
0034115073
-
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998
-
Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C (2000) Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother 45:457-466
-
(2000)
J Antimicrob Chemother
, vol.45
, pp. 457-466
-
-
Sahm, D.F.1
Jones, M.E.2
Hickey, M.L.3
Diakun, D.R.4
Mani, S.V.5
Thornsberry, C.6
-
13
-
-
0036732849
-
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin
-
Felmingham D, Reinert RR, Hirakata Y, Rodloff A (2002) Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 50(Suppl S1):25-37
-
(2002)
J Antimicrob Chemother
, vol.50
, Issue.SUPPL. S1
, pp. 25-37
-
-
Felmingham, D.1
Reinert, R.R.2
Hirakata, Y.3
Rodloff, A.4
-
14
-
-
0034118230
-
Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients
-
Bingen E, Fitoussi F, Doit C, Cohen R, Tanna A, George R, Loukil C, Brahimi N, Le Thomas I, Deforche D (2000) Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother 44:1453-1457
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 1453-1457
-
-
Bingen, E.1
Fitoussi, F.2
Doit, C.3
Cohen, R.4
Tanna, A.5
George, R.6
Loukil, C.7
Brahimi, N.8
Le Thomas, I.9
Deforche, D.10
-
15
-
-
0032955872
-
Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
-
Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, Rakowsky A, Schwartz B (1999) Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 18:1-9
-
(1999)
Pediatr Infect Dis J
, vol.18
, pp. 1-9
-
-
Dowell, S.F.1
Butler, J.C.2
Giebink, G.S.3
Jacobs, M.R.4
Jernigan, D.5
Musher, D.M.6
Rakowsky, A.7
Schwartz, B.8
-
16
-
-
0011561048
-
The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
-
Felmingham D, Grüneberg RN (2000) The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45:191-203
-
(2000)
J Antimicrob Chemother
, vol.45
, pp. 191-203
-
-
Felmingham, D.1
Grüneberg, R.N.2
-
17
-
-
0035904366
-
Macrolide resistance among invasive Streptococcus pneumoniae isolates
-
Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, Barrett NL, Schaffner W, Cieslak PR, Maupin PS, Zell ER, Jorgensen JH, Facklam RR, Whitney CG (2001) Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286:1857-1862
-
(2001)
JAMA
, vol.286
, pp. 1857-1862
-
-
Hyde, T.B.1
Gay, K.2
Stephens, D.S.3
Vugia, D.J.4
Pass, M.5
Johnson, S.6
Barrett, N.L.7
Schaffner, W.8
Cieslak, P.R.9
Maupin, P.S.10
Zell, E.R.11
Jorgensen, J.H.12
Facklam, R.R.13
Whitney, C.G.14
-
18
-
-
0036499021
-
Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia
-
Lynch JP III, Martinez FJ (2002) Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin Infect Dis 34(Suppl 1):S27-S46
-
(2002)
Clin Infect Dis
, vol.34
, Issue.1 SUPPL.
-
-
Lynch III, J.P.1
Martinez, F.J.2
-
19
-
-
0037308485
-
Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001
-
Reinert RR, Lutticken R, Bryskier A, Al-Lahham A (2003) Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother 47:489-493
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 489-493
-
-
Reinert, R.R.1
Lutticken, R.2
Bryskier, A.3
Al-Lahham, A.4
-
20
-
-
0034787718
-
Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study
-
Fluit AC, Wielders CL, Verhoef J, Schmitz FJ (2001) Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 39:3727-3732
-
(2001)
J Clin Microbiol
, vol.39
, pp. 3727-3732
-
-
Fluit, A.C.1
Wielders, C.L.2
Verhoef, J.3
Schmitz, F.J.4
-
21
-
-
85087227245
-
Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
-
Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, the SENTRY Partcipants Group (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 15:8114-S132
-
(2001)
Clin Infect Dis
, vol.15
, pp. 8114-S132
-
-
Diekema, D.J.1
Pfaller, M.A.2
Schmitz, F.J.3
Smayevsky, J.4
Bell, J.5
Jones, R.N.6
Beach, M.7
-
22
-
-
0036720269
-
Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000
-
Jones ME, Mayfield DC, Thornsberry C, Karlowsky JA, Sahm DF, Peterson D (2002) Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000. Antimicrob Agents Chemother 46:3104-3105
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 3104-3105
-
-
Jones, M.E.1
Mayfield, D.C.2
Thornsberry, C.3
Karlowsky, J.A.4
Sahm, D.F.5
Peterson, D.6
-
23
-
-
0036799604
-
Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population
-
Nakamura MM, Rohling KL, Shashaty M Lu H, Tang YW, Edwards KM (2002) Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J 21:917-922
-
(2002)
Pediatr Infect Dis J
, vol.21
, pp. 917-922
-
-
Nakamura, M.M.1
Rohling, K.L.2
Shashaty, M.3
Lu, H.4
Tang, Y.W.5
Edwards, K.M.6
-
24
-
-
0034881227
-
Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic
-
Hussain FM, Boyle-Vavra S, Daum RS (2001) Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J 20:763-767
-
(2001)
Pediatr Infect Dis J
, vol.20
, pp. 763-767
-
-
Hussain, F.M.1
Boyle-Vavra, S.2
Daum, R.S.3
-
26
-
-
0344526967
-
-
Roche Pharmaceuticals, Basel
-
Roche Pharmaceuticals (2000) Rocephin package insert. Roche Pharmaceuticals, Basel
-
(2000)
Rocephin Package Insert
-
-
|